Search

everythinglearnresearchcommunity

for

Search:↓

DHT, a testosterone byproduct, causes male pattern baldness.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Spironolactone plus finasteride reduces hirsutism more effectively.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Certain hormone treatments can improve acne and related conditions in women.

Sex hormones affect brain injury differently in males and females.

The normal human prostate does not significantly affect blood DHT levels.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.

Researchers created five new human scalp cell lines that could be useful for hair growth and loss research.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Testosterone helps human pancreatic cells increase insulin release.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Dosing time affects finasteride's effectiveness and safety in rats.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Effective treatments for excessive hair growth in women include creams, laser therapy, and medications, with the choice depending on individual needs and potential side effects.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Some supplements and hormones can increase hair loss by raising DHT levels.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

PCOS is a hormonal disorder causing infertility and menstrual problems, often linked to obesity and can lead to acne, treated with hormonal and insulin-sensitizing medications.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.